Therapeutic efficacy of a novel transdermal delivery system for (+)-PHNO in parkinsonian squirrel monkeys.
Rupniak
N M
NM
Tye
S J
SJ
Jennings
C A
CA
Loper
A E
AE
Bondi
J V
JV
Hichens
M
M
Iversen
S D
SD
Stahl
S M
SM
D000279:Administration, Cutaneous; D000818:Animals; D010078:Oxazines / Q000008:administration & dosage*; D010302:Parkinson Disease, Secondary / Q000188:drug therapy*; D012453:Saimiri
D010078:Oxazines; C042631:naxagolide